Effects of sevoflurane inhalation at different concentrations and at different times on intraoperative electrophysiological monitoring in patients with facial spasm

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000029843

Enrollment

Unknown

Registered

2020-02-15

Start date

2020-02-18

Completion date

Unknown

Last updated

2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

facial spasm

Interventions

Group 1:Sevoflurane 0.5MAC

Group 2:Sevoflurane0.75MAC

Group 3:Sevoflurane1MAC

Group 4:TIVA

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with facial spasm, schedueled for microvascular decompression, between the ages of 20 and 64 years old, regardless of gender, and an ASA grade of 1 or 2.

Exclusion criteria

Exclusion criteria: Excessive obesity, pregnant or nursing women, epileptic, existing neuromuscular diseases, family history of malignant high fever

Design outcomes

Primary

Measure	Time frame
amplitude of LSR;latency of LSR;	—

Secondary

Measure	Time frame
amplitude of facial EMG;latency of facial EMG;BP;HR;	—

Countries

China

Contacts

Public ContactLina Yang

Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital

605033376@qq.com+86 15928522804

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026